Kamp in MMM: Off-label Is on the Table

May 14, 2013 — In a Medical Marketing and Media (MMM) column posted May 1, Coalition for Healthcare Communication Executive Director John Kamp said that “although the FDA has been able to cling for decades to the idea that the approved label constitutes virtually the only truth about an approved product, good common sense and the First Amendment are closing in on the traditional regulatory scheme.” Kamp asserts in MMM that “the regulation of drug communication and marketing is on the brink of changes that will enable patients and doctors to garner valuable information from companies about the safe, effective and economically efficient use of drugs, especially for off-label uses.”